ESTRO37_ProgrammeBook

POSTERS

> Texture features to assess response to neoadjuvant therapy in locally advanced rectal cancer S. Mazzetti (Italy), A. Di Dia, V. Giannini, C. Bracco, S. Cauda, E. Delmastro, P. Gabriele, M. Stasi, T. Varetto, D. Regge > Poor prognostic and staging value of tumor deposits in rectal cancer with neoadjuvant chemoradiation Y. Wang (China), J. Zhang, L. Yang, W. Deng, L. Shen, L. Liang, M. Zhou, W. Yang, R. Hu, J. Zhu, Z. Zhang > Rectal cancer: multiparametric MRI assessment of tumour heterogeneity and chemoradiotherapy response T. Pham (Australia), G. Liney, K. Wong, C. Henderson, J.S. Shin, R. Rai, M. Lee, P. Graham, H.M. Hudson, N. Borok, M. Truong, M. Barton > Metformin with neoadjuvant chemoradiotherapy in the management of locally advanced rectal cancer T. Leroy (France), E. Bogart, E. Decoupigny, J.B. Prevost, N. Blanchard, L. Gilbeau, A. Henni, D. Carlier, O. Olsyk, M. Tokarski, X. Mirabel > Patient preferences for surgical and organ-sparing treatment approaches for rectal cancer A.M. Couwenberg (The Netherlands), M.P.W. Intven, J.P.M. Burbach, M.J. Emaus, W.M.U. Van Grevenstein, H.M. Verkooijen > Preoperative radiotherapy and local excision of rectal cancer: Results of a prospective study K. Wisniowska- Polish Colorectal Study Group (Poland) > Presence of High Risk HPV decreases odds of APR in patients with anal squamous cell cancer J. Jiang (USA), P. Wu, M. Tam, A. Lee, K. Du > Diffusion-weighted MRI for early assessment of tumor response in rectal cancer patients C. ROSA (Italy), R. Cianci, L. Caravatta, M. Di Tommaso, A. Delli Pizzi, S. Di Biase, F. Patani, D. Genovesi > High dose IMRT for locally advanced rectal cancer – late toxicity and patient-reported outcomes A.L. Appelt (United Kingdom), B.M. Havelund, H.S. Rønde, J. Pløen, I.R. Vogelius, A. Jakobsen

 PO-0790

 PO-0791

 PO-0792

 PO-0793

 PO-0794

 PO-0795

 PO-0796

 PO-0797

 PO-0798

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

202